Biotie Therapies Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
42
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
2
Biotie Therapies General Information
Description
Provider of drug development services designed for neurodegenerative and psychiatric disorders. The company's drug development services primarily focus on developing and selling therapeutics for central nervous system disorders, enabling medical institutes to treat and reduce alcohol consumption, Parkinson's disease, and other conditions.
Contact Information
Website
www.biotie.comCorporate Office
- Joukahaisenkatu 6
- 20520 Turku
- Finland
Corporate Office
- Joukahaisenkatu 6
- 20520 Turku
- Finland
Biotie Therapies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biotie Therapies Comparisons
Industry
Financing
Details
Biotie Therapies Competitors (75)
One of Biotie Therapies’s 75 competitors is Johnson&Johnson Innovative Medicine, a Venture Capital-Backed company based in Raritan, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| Dong-A ST Co | Corporation | Seoul, South Korea | ||||
| Sanofi Pasteur | Corporation | Paris, France | ||||
| Astrogen | Venture Capital-Backed | Daegu, South Korea | ||||
| Neurelis | Venture Capital-Backed | San Diego, CA |
Biotie Therapies Patents
Biotie Therapies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019405950-A1 | Methods for treating cancer using tozadenant | Inactive | 20-Dec-2018 | ||
| CA-3123856-A1 | Methods for treating cancer using tozadenant | Inactive | 20-Dec-2018 | ||
| EP-3897653-A1 | Methods for treating cancer using tozadenant | Inactive | 20-Dec-2018 | ||
| US-20220088024-A1 | Methods for treating cancer using tozadenant | Inactive | 20-Dec-2018 | ||
| AU-2017337053-A1 | Compositions and methods for treating alzheimer's disease and parkinson's disease | Active | 30-Sep-2016 | A61K31/17 |
Biotie Therapies Signals
Biotie Therapies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biotie Therapies Acquisitions (2)
Biotie Therapies’s most recent deal was a Merger/Acquisition with Synosia Therapeutics for . The deal was made on 01-Feb-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Synosia Therapeutics | 01-Feb-2011 | Merger/Acquisition | Drug Discovery | ||
| Elbion | 14-Nov-2008 | Merger/Acquisition | Drug Delivery |
Biotie Therapies FAQs
-
When was Biotie Therapies founded?
Biotie Therapies was founded in 1998.
-
Where is Biotie Therapies headquartered?
Biotie Therapies is headquartered in Turku, Finland.
-
What is the size of Biotie Therapies?
Biotie Therapies has 42 total employees.
-
What industry is Biotie Therapies in?
Biotie Therapies’s primary industry is Drug Discovery.
-
Is Biotie Therapies a private or public company?
Biotie Therapies is a Private company.
-
What is the current valuation of Biotie Therapies?
The current valuation of Biotie Therapies is .
-
What is Biotie Therapies’s current revenue?
The current revenue for Biotie Therapies is .
-
How much funding has Biotie Therapies raised over time?
Biotie Therapies has raised $79.2M.
-
Who are Biotie Therapies’s investors?
5AM Ventures, Aboa Venture Management, Alpine Investors, Aravis, and Burrill & Co are 5 of 20 investors who have invested in Biotie Therapies.
-
Who are Biotie Therapies’s competitors?
Johnson&Johnson Innovative Medicine, Dong-A ST Co, Sanofi Pasteur, Astrogen, and Neurelis are some of the 75 competitors of Biotie Therapies.
-
When was Biotie Therapies acquired?
Biotie Therapies was acquired on 18-Apr-2016.
-
Who acquired Biotie Therapies?
Biotie Therapies was acquired by Acorda Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process